$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Critical-sized bone defects pose significant clinical challenges in orthopedic treatment management. Per ASTM F2721, a critical-sized defect is characterized as a defect with a length 1.5 to 2 times the diameter of the bone of interest1. Repair of these defects has traditionally been through the use of autologous and allogeneic transplantations limited by the procedural expenses, associated risks of secondary surgeries, and bone graft volume required2. Current bone regeneration techniques focus on the use of allogeneic and xenogeneic scaffolds designed to produce both osteoconductive and osteoinductive effects through optimizing their mechanical properties, biocompatibility, bioactivity, angiogenic potential, and degradation profiles3,4,5. Biomaterials investigated broadly range from bioceramics and biopolymers to metals and other composite materials6. Variations of these biomaterials are tested both in vitro and in vivo to interrogate their potential as bone regeneration scaffolds.
µCT is the gold standard for non-invasive, high-accuracy imaging for the assessment of bone morphology, structure, and microstructure in rodent models7,8,9. This imaging modality has been described to assess the longitudinal, in vivo progression of bone regeneration in fracture healing models10. Methods have been developed to standardize the quantification of cortical and trabecular bone from µCT scans9. Semi-automated segmentation workflows have been developed utilizing commercially available visualization software for whole bone segmentation with complex anatomical structures11. These methods allow for simplified, approachable methods for users across varying experience levels to produce standardized, reproducible results. However, these methods remain limited in abilities to investigate user-defined ROI.
Here, we present a protocol that expands upon current methods to permit user-defined ROI bone volume analysis surrounding a critical-sized bone defect for longitudinal in vivo rat models using visualization software. Establishing a consistent alignment and ROI selection method between weeks of the longitudinal study was essential for the development of a robust protocol. An initial timepoint is used as the baseline for the alignment of subsequent weeks to ensure consistent orientation of solid models. Provided this alignment, corresponding µCT image slices from the overlayed solid models can be selected, encompassing the critical-sized defect. Consistent ROI is verified not only through slice location but also through comparison of the number of slices within the region. The selected ROI from the baseline model can then be replicated on subsequent weeks, allowing for comparative, quantitative analysis.